Details for Patent: 12,496,326
✉ Email this page to a colleague
Which drugs does patent 12,496,326 protect, and when does it expire?
Patent 12,496,326 protects VEVYE and is included in one NDA.
This patent has twenty-six patent family members in sixteen countries.
Summary for Patent: 12,496,326
| Title: | Ophthalmic composition for treatment of dry eye disease |
| Abstract: | The invention provides pharmaceutical compositions comprising about 0.05 to 0.1% (w/v) cyclosporine dissolved in 1-perfluorobutyl-pentane for use in the topical treatment of dry eye disease and provides for dosing and treatment methods thereof. The invention further provides kits comprising such compositions. |
| Inventor(s): | Markus Beier, Jörg HAISSER, Alice MEIDES, Sonja KRÖSSER, Hartmut Voss, Frank LÖSCHER, Bernhard Günther |
| Assignee: | Novaliq GmbH |
| Application Number: | US17/933,471 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 12,496,326
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Harrow Eye | VEVYE | cyclosporine | SOLUTION;OPHTHALMIC | 217469-001 | May 30, 2023 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | TREATMENT OF DRY EYE DISEASE (DED) | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,496,326
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2017384650 | ⤷ Start Trial | |||
| Brazil | 112019012791 | ⤷ Start Trial | |||
| Canada | 3045743 | ⤷ Start Trial | |||
| China | 110267645 | ⤷ Start Trial | |||
| China | 122005753 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
